IMCR - Immunocore GAAP EPS of -$0.04 beats by $0.32 revenue of $62.89M beats by $1.07M
2023-11-07 08:24:26 ET
More on Immunocore
- Immunocore: First Half Of 2024 IMC-F106C Data Expected
- Immunocore: KIMMTRAK Adoption Continues At Rapid Pace, Expanding To New Markets, Reiterate Buy
- Immunocore Holdings plc (IMCR) Q2 2023 Earnings Call Transcript
- Baird starts Immunocore at outperform, calls it "rare find" in biotech space
- Seeking Alpha’s Quant Rating on Immunocore
For further details see:
Immunocore GAAP EPS of -$0.04 beats by $0.32, revenue of $62.89M beats by $1.07M